1.5(top 50%)
impact factor
2.3K(top 10%)
papers
26.6K(top 10%)
citations
51(top 10%)
h-index
1.6(top 50%)
impact factor
2.7K
all documents
28.1K
doc citations
71(top 20%)
g-index

Top Articles

#TitleJournalYearCitations
1Gut microbiota dysbiosis in patients with non-alcoholic fatty liver diseaseHepatobiliary and Pancreatic Diseases International2017386
2Hepatocellular carcinoma: current management and recent advancesHepatobiliary and Pancreatic Diseases International2008302
3Inflammatory response of macrophages in infectionHepatobiliary and Pancreatic Diseases International2014146
4Detection of tumor stem cell markers in pancreatic carcinoma cell linesHepatobiliary and Pancreatic Diseases International2007140
5Severe acute pancreatitis: pathogenesis, diagnosis and surgical managementHepatobiliary and Pancreatic Diseases International2017109
6Primary graft dysfunction after liver transplantationHepatobiliary and Pancreatic Diseases International2014106
7Changes of gut bacteria and immune parameters in liver transplant recipientsHepatobiliary and Pancreatic Diseases International2012105
8Hepatic fibrosis: It is time to go with hepatic stellate cell-specific therapeutic targetsHepatobiliary and Pancreatic Diseases International2018104
9Circular RNA ciRS-7 promotes the proliferation and metastasis of pancreatic cancer by regulating miR-7-mediated EGFR/STAT3 signaling pathwayHepatobiliary and Pancreatic Diseases International2019104
10Interleukin-6: a villain in the drama of pancreatic cancer development and progressionHepatobiliary and Pancreatic Diseases International201492
11Pathophysiological consequences of obstructive jaundice and perioperative managementHepatobiliary and Pancreatic Diseases International201891
12Pathogenesis and treatment of parenteral nutrition-associated liver diseaseHepatobiliary and Pancreatic Diseases International201290
13Quantitative analysis of vascular endothelial growth factor, microvascular density and their clinicopathologic features in human hepatocellular carcinomaHepatobiliary and Pancreatic Diseases International200589
14Hepatocyte differentiation of mesenchymal stem cellsHepatobiliary and Pancreatic Diseases International201288
15Predictive value of C-reactive protein/albumin ratio in acute pancreatitisHepatobiliary and Pancreatic Diseases International201786
16Efficacy of intramuscular matrine in the treatment of chronic hepatitis BHepatobiliary and Pancreatic Diseases International200485
17Augmented reality technology for preoperative planning and intraoperative navigation during hepatobiliary surgery: A review of current methodsHepatobiliary and Pancreatic Diseases International201884
18Bedside index for severity in acute pancreatitis: comparison with other scoring systems in predicting severity and organ failureHepatobiliary and Pancreatic Diseases International201376
19Toll-like receptor 4 involvement in hepatic ischemia/reperfusion injury in miceHepatobiliary and Pancreatic Diseases International200470
20Portal vein thrombosisHepatobiliary and Pancreatic Diseases International200569
21Endobiliary radiofrequency ablation for malignant biliary obstructionHepatobiliary and Pancreatic Diseases International201367
22Risk factors associated with early and late recurrence after curative resection of hepatocellular carcinoma: a single institution's experience with 398 consecutive patientsHepatobiliary and Pancreatic Diseases International201466
23Classification of iatrogenic bile duct injuryHepatobiliary and Pancreatic Diseases International200766
24Crosstalk of liver immune cells and cell death mechanisms in different murine models of liver injury and its clinical relevanceHepatobiliary and Pancreatic Diseases International201765
25Obesity, fatty liver and liver cancerHepatobiliary and Pancreatic Diseases International200565
26Primary hepatic neuroendocrine carcinoma: clinical analysis of 11 casesHepatobiliary and Pancreatic Diseases International201065
27Nitrite-derived nitric oxide by xanthine oxidoreductase protects the liver against ischemia-reperfusion injuryHepatobiliary and Pancreatic Diseases International200564
28Specific molecular markers in hepatocellular carcinomaHepatobiliary and Pancreatic Diseases International200763
29APACHE system is better than Ranson system in the prediction of severity of acute pancreatitisHepatobiliary and Pancreatic Diseases International200662
30Gut microbiota and non-alcoholic fatty liver diseaseHepatobiliary and Pancreatic Diseases International201561
31Advances in preoperative assessment of liver functionHepatobiliary and Pancreatic Diseases International201460
32Propofol inhibits the adhesion of hepatocellular carcinoma cells by upregulating microRNA-199a and downregulating MMP-9 expressionHepatobiliary and Pancreatic Diseases International201359
33Role of MMP-2 and MMP-9 and their natural inhibitors in liver fibrosis, chronic pancreatitis and non-specific inflammatory bowel diseasesHepatobiliary and Pancreatic Diseases International201459
34Chimeric antigen receptor-engineered T-cell therapy for liver cancerHepatobiliary and Pancreatic Diseases International201859
35Association between vascular endothelial growth factor and metastasis after transcatheter arterial chemoembolization in patients with hepatocellular carcinomaHepatobiliary and Pancreatic Diseases International200459
36Clinicopathological characteristics of 15 patients with combined hepatocellular carcinoma and cholangiocarcinomaHepatobiliary and Pancreatic Diseases International200759
37Risk factors for early recurrence of small hepatocellular carcinoma after curative resectionHepatobiliary and Pancreatic Diseases International201059
38High-intensity focused ultrasound treatment for patients with unresectable pancreatic cancerHepatobiliary and Pancreatic Diseases International201258
39The International Study Group of Pancreatic Surgery definition of delayed gastric emptying and the effects of various surgical modifications on the occurrence of delayed gastric emptying after pancreatoduodenectomyHepatobiliary and Pancreatic Diseases International201758
40Recurrence and metastasis of hepatocellular carcinoma: progress and prospectsHepatobiliary and Pancreatic Diseases International200258
41Surgical treatment of xanthogranulomatous cholecystitis: experience in 33 casesHepatobiliary and Pancreatic Diseases International200758
42Diagnosis and treatment of polypoid lesions of the gallbladder: report of 194 casesHepatobiliary and Pancreatic Diseases International200457
43Evaluation of the updated definition of early allograft dysfunction in donation after brain death and donation after cardiac death liver allograftsHepatobiliary and Pancreatic Diseases International201256
44Neural invasion in pancreatic carcinomaHepatobiliary and Pancreatic Diseases International200256
45Immunomodulatory effects of mesenchymal stem cells derived from adipose tissues in a rat orthotopic liver transplantation modelHepatobiliary and Pancreatic Diseases International200856
46Role of nonsteroidal anti-inflammatory drugs in the prevention of post-ERCP pancreatitis: a meta-analysisHepatobiliary and Pancreatic Diseases International200956
47Harmine induces apoptosis in HepG2 cells via mitochondrial signaling pathwayHepatobiliary and Pancreatic Diseases International201155
48Clinicopathological features and prognosis of combined hepatocellular carcinoma and cholangiocarcinoma after surgeryHepatobiliary and Pancreatic Diseases International201455
49Th1 cytokine-based immunotherapy for cancerHepatobiliary and Pancreatic Diseases International201455
50Role of laparoscopic subtotal cholecystectomy in the treatment of complicated cholecystitisHepatobiliary and Pancreatic Diseases International200655